DPP4 and type 2 diabetes mellitus: Recently, DPP-4 inhibitors have become one of the most frequently prescribed medications for type 2 diabetes in Japan, and we have previously reported the efficacy of a DPP-4 inhibitor, sitagliptin, in Japanese patients with type 2 diabetes [9].